Target intelligence / Profile preview

Acyl-D-alanyl-D-alanine terminus of peptidoglycan precursor (D-Ala-D-Ala terminus)

Target
D-Ala-D-Ala terminus
Molecular classification
Other (non-protein molecular motif), Peptidoglycan precursor terminus
01

Overview

The acyl-D-alanyl-D-alanine terminus of peptidoglycan precursors is the carboxyl-terminal dipeptide sequence of the stem peptide in nascent bacterial peptidoglycan units, specifically found in Gram-positive and Gram-negative bacteria. It serves as the substrate for DD-transpeptidases (penicillin-binding proteins), which catalyze cross-linking essential for cell wall integrity. This motif is the target of β-lactam antibiotics, which mimic the D-Ala-D-Ala structure to bind and inhibit transpeptidase activity, and glycopeptide antibiotics, which physically bind to the motif and prevent cell wall synthesis. Modifications to this terminal group—such as replacement of the terminal D-Ala with D-Lac or D-Ser—confer resistance to glycopeptides by reducing antibiotic binding affinity. This motif is a classic, validated antimicrobial target but is not a receptor, enzyme, or protein—rather, it is a chemical motif critical for bacterial survival and cell division. Drugs acting on this target are foundational in the treatment of bacterial infections, particularly by disrupting the synthesis of the bacterial cell wall.

Other names
D-alanyl-D-alanine terminusAcyl-D-Ala-D-Ala groupPeptidyl-D-Ala-D-Ala extremityD-Ala-D-Ala motif
02

Mechanism of action

β-lactams: Covalent acylation of transpeptidase, preventing cross-linking by mimicking the D-Ala-D-Ala substrate. Glycopeptides: Steric blockade of the D-Ala-D-Ala motif, directly inhibiting transpeptidase and glycosyltransferase access.

03

Biological functions

Bacterial cell wall synthesisSubstrate for transpeptidase (cross-linking of peptidoglycan chains)
04

Disease associations

Infection (pathogenic bacteria)
05

Safety considerations

Not applicable for the target itself (peptidoglycan motif); safety concerns pertain to drugs interacting with it, such as allergic reactions to β-lactams or nephrotoxicity for glycopeptidesBacterial resistance by substitution of D-Ala-D-Ala with D-Ala-D-Lac or D-Ala-D-Ser, reducing antibiotic efficacy
06

Interacting drugs

β-lactams

3 more in the full profile.

07

Biomarkers

Presence of D-Ala-D-Ala terminus (predicts glycopeptide/β-lactam sensitivity)Changes to D-Ala-D-Lac or D-Ala-D-Ser terminus (predicts vancomycin resistance)

Beyond the preview

Go deeper on Acyl-D-alanyl-D-alanine terminus of peptidoglycan precursor (D-Ala-D-Ala terminus).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acyl-D-alanyl-D-alanine terminus of peptidoglycan precursor (D-Ala-D-Ala terminus).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call